Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Bertrand KNEBELMANN
Woman and Man Max 99 years
Bertrand KNEBELMANN
Update Il y a 4 ans
Phenylbutyrate in Proteinuric Nephropathies
The purpose of this study is to determine whether sodium phenylbutyrate can reduce Lcn2 urinary expression in proteinuric patients.
Country
France
organs
None
Specialty
None
Closed trial
More information